RE: Benchmark price was set @ 14.6667 pence14 Apr 2022 13:38
The SP is out of touch with reality now. This is a company heading into a fully funded phase 3 trial, likely within 12 months. You have pre-clinical nowhere's with much higher mcap's. 2 years to wait for what is on the cusp of transformational and this is 7p. Even with the history of this share, right now Lupuzor has never had more chance of success, de-risked yesterday massively. I don't even know why they even bother listing here, if I were the board I'd de-list and move the listing to the USA. UK stock market is broken, outside of the FTSE 100 everything is just throw a dart, no direct link to underlying value.